Article | April 23, 2021

Aseptic Environmental Monitoring For Vaccine Manufacturing

By Tim Russell

Vaccine manufactiring vials iStock-1292355769

Regulatory requirements do not change regardless of the scale of the operation. However, if scale up includes distribution to additional geographical regions, additional or different requirements may need to be met. In the United States (US) market, you must follow the Food and Drug Administration (FDA) Aseptic Processing Guide. Most other markets are guided by the harmonized Annex 1 of the European Union (EU), Pharmaceutical Inspection Co-operation Scheme (PIC/S), and World Health Organization (WHO) Good Manufacturing Practices (GMPs).

To meet immediate vaccine demand, aseptic manufacturing capacity must increase quickly. This means environmental monitoring programs must adapt rapidly as well. Thoughtful planning can help.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: